Anti-melanogenic effects of δ-tocotrienol are associated with tyrosinase-related proteins and MAPK signaling pathway in B16 melanoma cells

Lean Teik Ng, Liang Tzung Lin, Chiu Lan Chen, Hsiu Wen Chen, Shu Jing Wu, Chun Ching Lin

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Tocotrienols are known to possess potent antioxidant, anticancer, and cholesterol lowering activities. Being able to rapidly penetrate the skin, these vitamin E isoforms have been explored for potential treatment against melanoma. This study aimed to elucidate the mechanism involved in the anti-melanogenic effects of δ-tocotrienol (δT3) in B16 melanoma cells. Results showed that at 20 μM of δT3 significantly inhibited melanin formation and ROS generation. Treatment with δT3 also effectively suppressed the expression of melanogenesis-related proteins, including MC1R, MITF, TYRP-1, and TYRP-2. More importantly, we observed that the mitogen-activated protein kinase (MAPK) pathway was involved in mediating δT3's inhibitory effect against melanin production. Specifically, δT3 treatment markedly induced the activation of extracellular signal-regulated kinases (ERK). The use of ERK activation inhibitor (PD98059) abrogated the δT3-mediated downregulation expression melanogenesis-related proteins and restored melanin production. Furthermore, siRNA targeting ERK effectively blocked the δT3-induced repression of tyrosinase and TYRP-1 expression. These results suggest that δT3's inhibitory effect against melanogenesis is mediated by the activation of ERK signaling, thereby resulting in downstream repression of melanogenesis-related proteins and the subsequent melanin production. These data provide insight to δT3's effect and the targeting of ERK signaling for treatment against melanogenesis.

Original languageEnglish
Pages (from-to)978-983
Number of pages6
JournalPhytomedicine
Volume21
Issue number7
DOIs
Publication statusPublished - Jun 15 2014

Fingerprint

Tocotrienols
Experimental Melanomas
Monophenol Monooxygenase
Extracellular Signal-Regulated MAP Kinases
Mitogen-Activated Protein Kinases
Melanins
Proteins
Vitamin E
Small Interfering RNA
Melanoma
Protein Isoforms
Down-Regulation
Antioxidants
Cholesterol
Skin

Keywords

  • ERK activation
  • MAPK
  • Melanogenesis
  • Tocotrienols
  • Tyrosinase

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Pharmaceutical Science
  • Complementary and alternative medicine
  • Molecular Medicine
  • Medicine(all)

Cite this

Anti-melanogenic effects of δ-tocotrienol are associated with tyrosinase-related proteins and MAPK signaling pathway in B16 melanoma cells. / Ng, Lean Teik; Lin, Liang Tzung; Chen, Chiu Lan; Chen, Hsiu Wen; Wu, Shu Jing; Lin, Chun Ching.

In: Phytomedicine, Vol. 21, No. 7, 15.06.2014, p. 978-983.

Research output: Contribution to journalArticle

Ng, Lean Teik ; Lin, Liang Tzung ; Chen, Chiu Lan ; Chen, Hsiu Wen ; Wu, Shu Jing ; Lin, Chun Ching. / Anti-melanogenic effects of δ-tocotrienol are associated with tyrosinase-related proteins and MAPK signaling pathway in B16 melanoma cells. In: Phytomedicine. 2014 ; Vol. 21, No. 7. pp. 978-983.
@article{3c2c5408fe8548e3b75c4cc5513a0ff9,
title = "Anti-melanogenic effects of δ-tocotrienol are associated with tyrosinase-related proteins and MAPK signaling pathway in B16 melanoma cells",
abstract = "Tocotrienols are known to possess potent antioxidant, anticancer, and cholesterol lowering activities. Being able to rapidly penetrate the skin, these vitamin E isoforms have been explored for potential treatment against melanoma. This study aimed to elucidate the mechanism involved in the anti-melanogenic effects of δ-tocotrienol (δT3) in B16 melanoma cells. Results showed that at 20 μM of δT3 significantly inhibited melanin formation and ROS generation. Treatment with δT3 also effectively suppressed the expression of melanogenesis-related proteins, including MC1R, MITF, TYRP-1, and TYRP-2. More importantly, we observed that the mitogen-activated protein kinase (MAPK) pathway was involved in mediating δT3's inhibitory effect against melanin production. Specifically, δT3 treatment markedly induced the activation of extracellular signal-regulated kinases (ERK). The use of ERK activation inhibitor (PD98059) abrogated the δT3-mediated downregulation expression melanogenesis-related proteins and restored melanin production. Furthermore, siRNA targeting ERK effectively blocked the δT3-induced repression of tyrosinase and TYRP-1 expression. These results suggest that δT3's inhibitory effect against melanogenesis is mediated by the activation of ERK signaling, thereby resulting in downstream repression of melanogenesis-related proteins and the subsequent melanin production. These data provide insight to δT3's effect and the targeting of ERK signaling for treatment against melanogenesis.",
keywords = "ERK activation, MAPK, Melanogenesis, Tocotrienols, Tyrosinase",
author = "Ng, {Lean Teik} and Lin, {Liang Tzung} and Chen, {Chiu Lan} and Chen, {Hsiu Wen} and Wu, {Shu Jing} and Lin, {Chun Ching}",
year = "2014",
month = "6",
day = "15",
doi = "10.1016/j.phymed.2014.03.003",
language = "English",
volume = "21",
pages = "978--983",
journal = "Phytomedicine",
issn = "0944-7113",
publisher = "Urban und Fischer Verlag Jena",
number = "7",

}

TY - JOUR

T1 - Anti-melanogenic effects of δ-tocotrienol are associated with tyrosinase-related proteins and MAPK signaling pathway in B16 melanoma cells

AU - Ng, Lean Teik

AU - Lin, Liang Tzung

AU - Chen, Chiu Lan

AU - Chen, Hsiu Wen

AU - Wu, Shu Jing

AU - Lin, Chun Ching

PY - 2014/6/15

Y1 - 2014/6/15

N2 - Tocotrienols are known to possess potent antioxidant, anticancer, and cholesterol lowering activities. Being able to rapidly penetrate the skin, these vitamin E isoforms have been explored for potential treatment against melanoma. This study aimed to elucidate the mechanism involved in the anti-melanogenic effects of δ-tocotrienol (δT3) in B16 melanoma cells. Results showed that at 20 μM of δT3 significantly inhibited melanin formation and ROS generation. Treatment with δT3 also effectively suppressed the expression of melanogenesis-related proteins, including MC1R, MITF, TYRP-1, and TYRP-2. More importantly, we observed that the mitogen-activated protein kinase (MAPK) pathway was involved in mediating δT3's inhibitory effect against melanin production. Specifically, δT3 treatment markedly induced the activation of extracellular signal-regulated kinases (ERK). The use of ERK activation inhibitor (PD98059) abrogated the δT3-mediated downregulation expression melanogenesis-related proteins and restored melanin production. Furthermore, siRNA targeting ERK effectively blocked the δT3-induced repression of tyrosinase and TYRP-1 expression. These results suggest that δT3's inhibitory effect against melanogenesis is mediated by the activation of ERK signaling, thereby resulting in downstream repression of melanogenesis-related proteins and the subsequent melanin production. These data provide insight to δT3's effect and the targeting of ERK signaling for treatment against melanogenesis.

AB - Tocotrienols are known to possess potent antioxidant, anticancer, and cholesterol lowering activities. Being able to rapidly penetrate the skin, these vitamin E isoforms have been explored for potential treatment against melanoma. This study aimed to elucidate the mechanism involved in the anti-melanogenic effects of δ-tocotrienol (δT3) in B16 melanoma cells. Results showed that at 20 μM of δT3 significantly inhibited melanin formation and ROS generation. Treatment with δT3 also effectively suppressed the expression of melanogenesis-related proteins, including MC1R, MITF, TYRP-1, and TYRP-2. More importantly, we observed that the mitogen-activated protein kinase (MAPK) pathway was involved in mediating δT3's inhibitory effect against melanin production. Specifically, δT3 treatment markedly induced the activation of extracellular signal-regulated kinases (ERK). The use of ERK activation inhibitor (PD98059) abrogated the δT3-mediated downregulation expression melanogenesis-related proteins and restored melanin production. Furthermore, siRNA targeting ERK effectively blocked the δT3-induced repression of tyrosinase and TYRP-1 expression. These results suggest that δT3's inhibitory effect against melanogenesis is mediated by the activation of ERK signaling, thereby resulting in downstream repression of melanogenesis-related proteins and the subsequent melanin production. These data provide insight to δT3's effect and the targeting of ERK signaling for treatment against melanogenesis.

KW - ERK activation

KW - MAPK

KW - Melanogenesis

KW - Tocotrienols

KW - Tyrosinase

UR - http://www.scopus.com/inward/record.url?scp=84901638718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901638718&partnerID=8YFLogxK

U2 - 10.1016/j.phymed.2014.03.003

DO - 10.1016/j.phymed.2014.03.003

M3 - Article

C2 - 24680613

AN - SCOPUS:84901638718

VL - 21

SP - 978

EP - 983

JO - Phytomedicine

JF - Phytomedicine

SN - 0944-7113

IS - 7

ER -